Skip to content

We are supported by referral fees from the advertisers presented on this site. We do not present information about every advertiser or offer available.

Semaglutide.now
Semaglutide

Found vs JoinFridays: Personalized care vs no-contract pricing

Found vs JoinFridays compares two telehealth GLP-1 options with different priorities: Found emphasizes a biology-first personalized program and insurance support, while JoinFridays emphasizes no-contract pricing and aggressive promo codes. Early verdict: pick Found if you need insurance support and a holistic, medically supervised program; pick JoinFridays if you want the lowest starting compound price with flexible cancellation.

Explore Found plans starting as low as $39

Found vs JoinFridays: what each emphasizes

Both platforms provide clinician-reviewed GLP-1 programs, but their emphases differ. Found markets a biology-first, personalized medically supervised weight loss program that targets hormones, metabolism, sleep, and behavior, and advertises getting started for as low as $39 with most insurance accepted. JoinFridays positions itself around flexible membership terms, competitive compound pricing starting at $117/month, no long-term contracts, and active promo codes for tirzepatide and semaglutide.

Direct comparison table

Criteria Found JoinFridays
Starting price Get started for as low as $39 Starting at $117/month
Medication options Semaglutide, tirzepatide; mentions compounded options Compounded semaglutide and tirzepatide; brand options noted separately
Insurance support Most insurance now accepted; insurance paperwork handled by Found No insurance required; name brand pricing listed but core messaging is no insurance needed
Membership & contracts Affordable monthly plans; cancel anytime; membership tiers noted No membership fees, cancel anytime, no long-term contract
Personalization Biology-based personalized plans and medically supervised program Personalized clinician-guided care with dosing guidance
Regulatory note Compounded GLP-1s are not FDA-approved and not evaluated for safety or efficacy Compounded medications are not FDA-approved and not reviewed by FDA for safety or quality

Pricing and payment structure

Found advertises getting started for as low as $39 and mentions multiple membership price points and insurance handling, with statements like “Get Wegovy®, Foundayo®, or Zepbound® for as little as $50/mo through Medicare” and various membership starting levels. JoinFridays lists compound pricing starting at $117/month, notes a one-month standalone price and multi-month plans that lower effective monthly cost, and highlights active promo codes such as NEWYOU12 and NYNY12 for up to $500 or $400 off selected programs. The evidence supplied does not give a single apples-to-apples total cost comparison for equivalent medication protocols, only the platform starting points and membership structures.

See JoinFridays pricing starting at $117/mo

Medication access and clinical oversight

Both providers offer clinician-reviewed programs and supply compounded GLP-1 options. Found states it provides semaglutide and tirzepatide and explicitly notes that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and that Rx is subject to provider review and clinical eligibility. JoinFridays provides compounded semaglutide and tirzepatide options, emphasizes personalized clinician-guided care, and likewise notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.

Check Found clinician-reviewed programs

Insurance, contracts, and patient fit

Found highlights insurance acceptance, handling insurance paperwork, and specific Medicare bridge programs that may lower brand-name copays to as little as $50/month for eligible Part D members, while cautioning that coverage, copays, and eligibility vary and that advertised pricing may require commitments. JoinFridays emphasizes no membership fees and the ability to cancel anytime with no long-term contract, positioning itself for patients who want to trial therapy without a long commitment. If insurance support is important, the supplied facts show Found actively works with insurance; if contract freedom and clear no-fee cancellation are priorities, JoinFridays highlights that feature.

Safety, regulatory notes, and limitations

Both sources include regulatory cautions about compounded medications. Found explicitly states that compounded GLP-1s are not FDA-approved and not evaluated for safety or efficacy, and that certain medications are FDA-approved for conditions other than weight. JoinFridays similarly notes that compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality. Both platforms require clinician review and clinical eligibility for treatment.

Conclusion: Found vs JoinFridays

Found vs JoinFridays boils down to priorities. Found centers on a biology-first, personalized medically supervised program with broad insurance support and advertised entry pricing as low as $39. JoinFridays centers on no-contract flexibility, compounded GLP-1 options with a lowest-tier start at $117/month, and aggressive promo codes that lower effective cost for some patients.

Start with Found for insurance-friendly, biology-first care

Choose Found if you want a program built around your metabolic biology and insurance handling. Choose JoinFridays if you want the lowest starting compound price in its tier, no long-term contract, and active promo codes. Both platforms require clinician review and note that compounded GLP-1s are not FDA-approved; weigh those regulatory notes alongside price and personalization features when deciding.

Choose JoinFridays for no-contract pricing and promo codes

Ready to Compare GLP-1 Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.